PYOTT DAVID E I
SEC Form 4 insider trading activity
PYOTT DAVID E I has filed 4 SEC Form 4 filings (9 transaction rows) across 2 companies, including TARS, ALNY, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 17, 2026.
On the most recent filing, PYOTT DAVID E I is listed as Director at ALNYLAM PHARMACEUTICALS, INC. Inside the rolling window, PYOTT DAVID E I reported no open-market purchases and 1 open-market sale totaling $1.1M in ALNY.
Companies traded
Other insiders at TARS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has PYOTT DAVID E I made?
PYOTT DAVID E I has filed 4 SEC Form 4 filings (9 transaction rows) across 2 companies, including TARS, ALNY since 2026.
Which companies does PYOTT DAVID E I trade?
PYOTT DAVID E I has filed SEC Form 4 disclosures for 2 companies, including TARS, ALNY.
When was PYOTT DAVID E I's most recent SEC Form 4 filing?
PYOTT DAVID E I's most recent SEC Form 4 filing on Tracefour is dated Sep 17, 2026.
What is PYOTT DAVID E I's total buy and sell value in the current window?
Inside the rolling retention window, PYOTT DAVID E I bought $0 and sold $1.1M based on SEC Form 4 filings.
What was PYOTT DAVID E I's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,830 ALNY shares on 2026-06-01, worth $1.1M, per SEC Form 4 filings.